INDUSTRY INSIGHTS

• IND-Enabling Programs For Adoptive Cell Therapies

  Accelerating the development of adoptive cell therapies through robust preclinical strategies and regulatory pathways is crucial to bringing these life-saving treatments to patients in need.

• Advancing Treatments For Pediatric Patients With Rare Diseases

  Advancing cell and gene therapies for rare pediatric diseases requires overcoming unique challenges in trial design, patient access, and long-term follow-up.

• Overcoming Challenges For Rare Disease In Pediatrics

  Advancing cell and gene therapies for rare pediatric diseases will require innovative trial strategies, early diagnosis, and improved treatment technologies.

• Addressing Challenges And De-Risking Clinical Oncology Development

  See why collaboration and innovation are key to overcoming challenges and bringing life-changing cell and gene therapies to those in need.

• The Importance Of Designing Trials, Strategies With The End Goals In Mind

  Ensure the success of your CGT program by strategically planning early, aligning regulatory and clinical pathways, and partnering with experienced experts to navigate development complexities.

• 5 Surprising Factors That Influence Your Road To The Clinic

  Examine the factors that impact CGT timelines during the preclinical phase and offer actionable strategies to help ensure timely and cost-effective IND filing.

• A Standardized T Cell Backbone Panel For Immune Monitoring Of Adoptively Transferred Cellular Therapies

  This validated 22-marker flow cytometry panel enables deep immune profiling to identify key biomarkers influencing ACT efficacy — optimizing cell therapy outcomes and improving patient responses.

• Biodistribution Of AAV6.2-mCherry In C57BL/6J Mouse Dosed Via Nose-Only Inhalation Route

  Explore how a rodent nose-only AAV inhalation model can optimize the safe and effective delivery of aerosolized gene therapies for monogenic pulmonary diseases.

• A New 30-Color Spectral Flow Cytometry Panel For T Cell Therapy Phenotypic Characterization

  Explore how Labcorp's 30-color immunophenotyping panel, powered by Cytek Aurora™ Spectral Flow Cytometry, can enhance your T cell therapy studies across in vitro, preclinical, and clinical stages.

• Seamless End-To-End Logistical Coordination In CAR T-Cell Therapies

  Ensure the success of CAR T-cell therapies by partnering with a reliable logistics system that maintains sample integrity throughout the entire process, from collection to reinfusion.